Jacob’s case study is quite an important one to share.
Jacob has a milder form of Cerebral Palsy, where he can walk by himself in a walker, but needed help in improving his gait. He also has some speech difficulties, but his cognition is perfectly fine. Jacob’s family got the Trexo in November 2019 hoping to see some benefits from it.
As soon as they started using the device, they started noticing improvements in his walking and overall strength and balance. Continue reading “Trexo Robotics – Benefits during COVID – Meet Jacob”
Can psychedelic drugs help people living with anxiety, depression and post-traumatic stress disorder (PTSD)?
We explored this question at the first session of “Great Conversations: The Mind Series” in partnership with the Ontario Science Centre. “Science Meets Psychedelics” hosted by Dan Riskin, an evolutionary biologist and former TV co-host of Daily Planet, featured panelists Norman Farb, PhD, Associate Professor of Psychology at the University of Toronto and Anne Wagner, PhD, Clinical psychologist, Founder of Remedy and Adjunct Professor at Ryerson University.
Continue reading “The Mind Series: Science Meets Psychedelics”
When Britain appointed Tracey Crouch its first Minister of Loneliness, most people found it humorous. The apparent silliness of that appointment quickly subsided and provoked important questions about mental health, extending beyond Britain’s borders. Is this issue true to Britain alone? And is loneliness no longer a personal matter? The Jo Cox Commission on Loneliness that urged Britain to act revealed more than 9 million people in Britain – around 14 percent of the population – often or always feel lonely, costing employers up to $3.5 billion annually, not to mention the personal costs in wellbeing. Continue reading “Mental Health is Brain Health – A paradigm shift”